triazoles has been researched along with Friedreich Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frigon, NL; Miller, JL; Pandolfo, M; Punnonen, J; Rai, M; Spencer, JR | 1 |
| Corey, DR; Damha, MJ; Li, L; Liu, Z; Norrbom, M; O'Reilly, D; Prakash, TP; Rigo, F; Sharma, VK; Shen, X; Watts, JK | 1 |
2 other study(ies) available for triazoles and Friedreich Disease
| Article | Year |
|---|---|
Erythropoietin and small molecule agonists of the tissue-protective erythropoietin receptor increase FXN expression in neuronal cells in vitro and in Fxn-deficient KIKO mice in vivo.
Topics: Adult; Animals; Cells, Cultured; Cerebral Cortex; Erythropoietin; Female; Frataxin; Friedreich Ataxia; Histone Deacetylase Inhibitors; Humans; Iron-Binding Proteins; Leukocytes, Mononuclear; Male; Mice, Inbred C57BL; Mice, Transgenic; Middle Aged; Neurons; Neuroprotective Agents; Pyrimidines; Receptors, Erythropoietin; Recombinant Proteins; Triazoles; Young Adult | 2017 |
Activation of Frataxin Protein Expression by Antisense Oligonucleotides Targeting the Mutant Expanded Repeat.
Topics: Adolescent; Adult; Cell Line; Child; Female; Fibroblasts; Frataxin; Friedreich Ataxia; Gene Expression Regulation; Genetic Therapy; Humans; Introns; Iron-Binding Proteins; Male; Oligonucleotides; Oligonucleotides, Antisense; Primary Cell Culture; RNA, Double-Stranded; RNA, Messenger; Triazoles; Trinucleotide Repeat Expansion | 2018 |